Actively Recruiting
Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients
Led by Sixth Affiliated Hospital, Sun Yat-sen University · Updated on 2023-05-24
366
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial\] is to compare in resectable stage T3-4N2 colorectal cancer. The main question it aims to answer is: whether the use of targeted therapy in combination with adjuvant chemotherapy is associated with improved disease-free survival (DFS) compared to adjuvant chemotherapy alone.
CONDITIONS
Official Title
Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Both sexes, aged 18-75 years
- Pathologically confirmed pT3-4N2 stage colorectal adenocarcinoma after surgery
- ASA grade less than IV and/or ECOG performance status score 2 or less
- Fully understand and voluntarily sign the informed consent form for this study
You will not qualify if you...
- History of other malignant tumors
- Severe liver, kidney, cardio-pulmonary, or coagulation dysfunction or underlying diseases that prevent chemotherapy
- Allergy to any study components
- Severe uncontrollable recurrent infections or other severe diseases
- Factors affecting study results or causing early withdrawal such as alcoholism, drug abuse, serious diseases including mental illness, or severe lab abnormalities
- Emergent surgery due to intestinal obstruction, perforation, bleeding, etc.
- History of severe mental illness
- Pregnant or lactating women
- Other clinical or laboratory conditions deemed inappropriate by investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Sixth Affiliate Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here